Budget 2018-19

 In Tamil Nadu, apart from online registration, the state administration also allowed people to walk in and register for coronavirus vaccinations in phase-2. Since Monday morning the vaccination center at the government hospital in Chennai was unusually busy as people walked in to get the Coronavirus vaccine shotThe situation was similar at various government hospitals in Chennai In Tamil Nadu, apart from online registration, the state administration also allowed people to walk in and register for vaccinations Seventy-year old S Jayaraman, who reached the government general hospital in Chennai at 8.30am waited patiently for his turn to register. He said he was not anxious ahead of taking the taking the vaccine and authorities had told him that he could choose the vaccine. Next to Apollo’s main hospital in Chennai, a vaccination center run by the hospital saw a good response. Fifty-eight-year old Venkatramaih, executive director of an automobile company walked into Apollo’s center t...

  Data from global trials to be submitted to the Indian regulator by the end of December     The AstraZeneca-Oxford vaccine candidate has shown positive results in an interim analysis of clinical trials in the UK and Brazil, with a vaccine efficacy of up to 90 per cent in different dosing regimens. Data from the global trials would be submitted to the Indian regulator by the end of December, and Serum Institute of India (SII), AstraZeneca’s manufacturing partner here, would submit the interim data from the Indian arm by then, sources said. “It is up to the Indian regulator to decide which dosage form it would approve for the Indian population. Data from all the dosage forms will be presented before the regulator,” a source said. The recruitment for the 1,600-volunteer Indian arm of the Covishield vaccine trial is over and the trial is in the last leg. The regimen, with one half dose followed by a full dose after a month, has shown 90 per cent efficacy. This would enable m...